Le Lézard
Classified in: Health
Subject: PER

For Eyes by GrandVision Announces Magda Nogueras, O.D. As Vice President, Professional Services


MIRAMAR, Fla., May 18, 2018 /PRNewswire/ -- For Eyes Optical, a division of GrandVision N.V., has announced the addition of Dr. Magda Nogueras, O.D. as its Vice President of Professional Services.

In this role, Dr. Nogueras will assume responsibilities for all functions within the Professional Services organization, including most optometric relations, recruiting, scheduling, contracting, and issues resolution. She will be called upon to interpret and understand state and federal laws regarding optometric affiliation, managed vision credentialing, obtaining optometric equipment and office management systems. The role will also involve developing coverage strategies and working with Retail Operations to ensure best optometry/retail affiliations.

"Dr. Nogueras represents an incredible addition at this position for our brand and will be an enormous asset for our doctors, who represent some of our most valuable assets," said For Eyes CEO Jose Costa. "Her experience working with the franchise model and within the corridors of some of our largest competitors will prove invaluable as we look to a bright future."

Dr. Nogueras, a native of Puerto Rico, joins the Florida-based healthcare brand following leadership positions at eyewear brands like Lenscrafters, Pearle Vision and Luxottica.

About For Eyes by GrandVision 

For Eyes was founded in 1972 in Philadelphia, PA on the foundation that an optical store should have a friendly open environment with fair pricing and high-quality standards. Throughout the years, For Eyes has grown to 116 stores across the United States. In December of 2015 For Eyes became a part of GrandVision, the global leader in optical retail. We leverage this global knowledge in eye care, technology & products to provide the highest level of service in each of our stores.

About GrandVision 

GrandVision is the global leader in optical retail by number of stores (excluding sunglass specialty stores) and delivers high quality and affordable eye care to more and more customers around the world. The high quality eye care offered by GrandVision includes a wide range of services provided by its optical experts, prescription glasses including frames and lenses, contact lenses and contact lens care products, and sunglasses both plain and with prescription lenses. These products are offered through its leading optical retail banners, which operate in 43 countries across Europe, Latin America, the Middle East and Asia. GrandVision serves its customers in over 6,700 stores and with more than 26,600 full time equivalent employees, which are proving every day that in eye care, we care more. For more information, please visit www.grandvision.com.

Media Contact: (305) 731-2224, [email protected]

SOURCE For Eyes by GrandVision


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with platinum-containing chemotherapy as neoadjuvant treatment, then...

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: